Several subsequent studies confirmed these findings, including a study by Bogovič et al. (2022) [29] showing an elevated expression of CXCL11 and CXCL13 (a chemokine regulating the biology of B-cells) in the serum of TBE patients along with a distinct cytokine/chemokine expression pattern in the CSF that included CXCL10 and CCL19. This evidence concerns the gene CXCL13 and tick-borne encephalitis.